Bearish flow noted in Immunovant with 4,028 puts trading, or 2.0x expected. Most active are Dec-23 22.5 puts and Oct-23 35 puts, with total volume in those strikes near 2,500 contracts. The Put/Call Ratio is 10.71, while ATM IV is up nearly 6 points on the day. Earnings are expected on November 3rd.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IMVT:
- Immunovant 7.37M share Secondary priced at $38.00
- Immunovant Announces Pricing of $450 Million Common Stock Financing
- Immunovant price target raised to $48 from $32 at Guggenheim
- Immunovant price target raised to $48 from $33 at Wells Fargo
- Immunovant price target raised to $49 from $29 at BofA
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue